Methylphenidate and a Nursing Telephone Intervention for Fatigue

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

January 9, 2007

Primary Completion Date

November 22, 2021

Study Completion Date

November 22, 2021

Conditions
Advanced CancerFatigue
Interventions
DRUG

Methylphenidate

5 mg (one capsule) orally every two hours as needed up to a maximum of 20 mg per day for a period of 14 days.

BEHAVIORAL

Nursing Telephone Intervention

Call from study nurse 3 times weekly to ask about side effects and other symptoms.

DRUG

Placebo

One capsule, orally every two hours as needed up to a maximum of 4 capsules per day for a period of 14 days.

BEHAVIORAL

Non NTI

Non NTI are calls from research staff 3 times weekly.

Trial Locations (2)

77026

Lyndon Baines Johnson (LBJ) Hospital, Houston

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00424099 - Methylphenidate and a Nursing Telephone Intervention for Fatigue | Biotech Hunter | Biotech Hunter